Overview
Yue Teng practices in Nanjing, China. Teng is rated as an Advanced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Their top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Cerebral Hypoxia.
Their clinical research consists of co-authoring 59 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaTeng isAdvanced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaTeng isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Cerebral HypoxiaTeng isExperienced. Learn about Cerebral Hypoxia.
- Endometrial CancerTeng isExperienced. Learn about Endometrial Cancer.
- Follicular LymphomaTeng isExperienced. Learn about Follicular Lymphoma.
- Lung AdenocarcinomaTeng isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerTeng isExperienced. Learn about Lung Cancer.
- Mediastinal TumorTeng isExperienced. Learn about Mediastinal Tumor.